Home
>
National Drug Code (NDC)
>
Zyclara
Zyclara - 29336-750-75 - (imiquimod)
Drug Information of Zyclara
| Product NDC: | 29336-750 |
| Proprietary Name: | Zyclara |
| Non Proprietary Name: | imiquimod |
| Active Ingredient(s): | 3.75 mg/100mg & nbsp; imiquimod |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zyclara
| Product NDC: | 29336-750 |
| Labeler Name: | Graceway Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022483 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111015 |
Package Information of Zyclara
| Package NDC: | 29336-750-75 |
| Package Description: | 7500 mg in 1 BOTTLE, PUMP (29336-750-75) |
NDC Information of Zyclara
| NDC Code | 29336-750-75 |
| Proprietary Name | Zyclara |
| Package Description | 7500 mg in 1 BOTTLE, PUMP (29336-750-75) |
| Product NDC | 29336-750 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | imiquimod |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20111015 |
| Marketing Category Name | NDA |
| Labeler Name | Graceway Pharmaceuticals, LLC |
| Substance Name | IMIQUIMOD |
| Strength Number | 3.75 |
| Strength Unit | mg/100mg |
| Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
